Twist Bioscience Corp (NASDAQ: TWST) on Monday, plunged -3.37% from the previous trading day, before settling in for the closing price of $31.19. Within the past 52 weeks, TWST’s price has moved between $24.07 and $55.33.
Annual sales at Healthcare sector company grew by 1.70% over the past five years. The company achieved an average annual earnings per share of 63.55%. With a float of $57.71 million, this company’s outstanding shares have now reached $60.17 million.
Let’s look at the performance matrix of the company that is accounted for 923 employees.
Twist Bioscience Corp (TWST) Insider Updates
Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of Twist Bioscience Corp is 4.40%, while institutional ownership is 115.54%. The most recent insider transaction that took place on Oct 08 ’25, was worth 93,450. In this transaction Chief Financial Officer of this company sold 3,000 shares at a rate of $31.15, taking the stock ownership to the 94,042 shares. Before that another transaction happened on Oct 09 ’25, when Company’s Chief Financial Officer sold 2,517 for $32.92, making the entire transaction worth $82,865. This insider now owns 91,525 shares in total.
Twist Bioscience Corp (TWST) Performance Highlights and Predictions
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.59 earnings per share (EPS) for the period topping the consensus outlook (set at -0.69) by 0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.52 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 63.55% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 35.91% during the next five years compared to 1.70% growth over the previous five years of trading.
Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators
Twist Bioscience Corp (TWST) is currently performing well based on its current performance indicators. A quick ratio of 3.60 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.02.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.45, a number that is poised to hit -0.41 in the next quarter and is forecasted to reach -1.34 in one year’s time.
